This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tuveson, D. A. Articles by Konieczny, S. F. Search for Related Content PubMed PubMed Citation Articles by Tuveson, D. A. Articles by Konieczny, S. F.

Mist1-Kras^G12D Knock-In Mice Develop Mixed Differentiation Metastatic Exocrine Pancreatic Carcinoma and Hepatocellular Carcinoma

Departments of ¹ Medicine and ² Cancer Biology, Abramson Family Cancer Research Institute; ³ Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania; ⁴ Department of Biological Sciences and the Purdue Cancer Center, Purdue University, West Lafayette, Indiana; ⁵ Massachusetts Institute of Technology Cancer Center and Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts; and ⁶ Departments of Pathology and Oncology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland

Requests for reprints: David A. Tuveson, Department of Medicine, University of Pennsylvania, 512 BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104-6160. Phone: 215-746-5560; Fax: 215-573-2486; E-mail: tuvesond{at}mail.med.upenn.edu or Stephen F. Konieczny, Department of Biological Sciences and the Purdue Cancer Center, Purdue University, Hansen Life Sciences Research Building, West Lafayette, IN 47907-2064. Phone: 765-494-7976; Fax: 765-496-2536; E-mail: sfk{at}bilbo.bio.purdue.edu.

Despite the prevalence of oncogenic Kras mutations in the earliest stages of pancreatic ductal adenocarcinoma, the cellular compartment in which oncogenic Kras initiates tumorigenesis remains unknown. To address this, we have gene targeted Kras^G12D into the open reading frame of Mist1, a basic helix-loop-helix transcription factor that is expressed during pancreatic development and required for proper pancreatic acinar organization. Although the pancreata of Mist1^KrasG12D/+ mutant mice predictably exhibited acinar metaplasia and dysplasia, the frequent death of these mice from invasive and metastatic pancreatic cancer with mixed histologic characteristics, including acinar, cystic, and ductal features, was unexpected and in contrast to previously described mutant mice that ectopically expressed the Kras oncogene in either acinar or ductal compartments. Interestingly, many of the mutant mice developed hepatocellular carcinoma, implicating Mist1^KrasG12D/+ cells in both pancreatic and hepatic neoplasia. Concomitant Trp53^+/– mutation cooperated with Mist1^KrasG12D/+ to accelerate lethality and was associated with advanced histopathologic findings, including parenchymal liver metastasis. These findings suggest that Mist1-expressing cells represent a permissive compartment for transformation by oncogenic Kras in pancreatic tumorigenesis. (Cancer Res 2006; 66(1): 242-7)

This article has been cited by other articles:

				J.-P. De La O, L. L. Emerson, J. L. Goodman, S. C. Froebe, B. E. Illum, A. B. Curtis, and L. C. Murtaugh Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia PNAS, December 2, 2008; 105(48): 18907 - 18912. [Abstract] [Full Text] [PDF]

				N. Habbe, G. Shi, R. A. Meguid, V. Fendrich, F. Esni, H. Chen, G. Feldmann, D. A. Stoffers, S. F. Konieczny, S. D. Leach, et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice PNAS, December 2, 2008; 105(48): 18913 - 18918. [Abstract] [Full Text] [PDF]

				A. F. Hezel, S. Gurumurthy, Z. Granot, A. Swisa, G. C. Chu, G. Bailey, Y. Dor, N. Bardeesy, and R. A. DePinho Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms Mol. Cell. Biol., April 1, 2008; 28(7): 2414 - 2425. [Abstract] [Full Text] [PDF]

				K. Kojima, S. M. Vickers, N. V. Adsay, N. C. Jhala, H.-G. Kim, T. R. Schoeb, W. E. Grizzle, and C. A. Klug Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia Cancer Res., September 1, 2007; 67(17): 8121 - 8130. [Abstract] [Full Text] [PDF]

				L. Zhu, G. Shi, C. Max. Schmidt, R. H. Hruban, and S. F. Konieczny Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia Am. J. Pathol., July 1, 2007; 171(1): 263 - 273. [Abstract] [Full Text] [PDF]

				P. M. Campbell, A. L. Groehler, K. M. Lee, M. M. Ouellette, V. Khazak, and C. J. Der K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase Signaling Cancer Res., March 1, 2007; 67(5): 2098 - 2106. [Abstract] [Full Text] [PDF]

				W Greenhalf An unfavourable prognosis for pancreatic cancer indicates fields of opportunity. Gut, November 1, 2006; 55(11): 1533 - 1535. [Full Text] [PDF]

				A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev., May 15, 2006; 20(10): 1218 - 1249. [Abstract] [Full Text] [PDF]

				R. H. Hruban, N. V. Adsay, J. Albores-Saavedra, M. R. Anver, A. V. Biankin, G. P. Boivin, E. E. Furth, T. Furukawa, A. Klein, D. S. Klimstra, et al. Pathology of Genetically Engineered Mouse Models of Pancreatic Exocrine Cancer: Consensus Report and Recommendations Cancer Res., January 1, 2006; 66(1): 95 - 106. [Abstract] [Full Text] [PDF]

				D.A. TUVESON and S.R. HINGORANI Ductal Pancreatic Cancer in Humans and Mice Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 65 - 72. [Abstract] [PDF]